Sino Biopharmaceutical (HKSE:01177) Dividend Payout Ratio : 0.36 (As of Jun. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Sino Biopharmaceutical Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sino Biopharmaceutical's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.36.

The historical rank and industry rank for Sino Biopharmaceutical's Dividend Payout Ratio or its related term are showing as below:

HKSE:01177' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.24 Max: 0.84
Current: 0.38

During the past 13 years, the highest Dividend Payout Ratio of Sino Biopharmaceutical was 0.84. The lowest was 0.05. And the median was 0.24.

HKSE:01177's Dividend Payout Ratio is ranked better than
61.76% of 136 companies
in the Biotechnology industry
Industry Median: 0.47 vs HKSE:01177: 0.38

As of today (2025-03-02), the Dividend Yield % of Sino Biopharmaceutical is 1.86%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Sino Biopharmaceutical was 3.63%. The lowest was 0.37%. And the median was 0.76%.

Sino Biopharmaceutical's Dividends per Share for the months ended in Jun. 2024 was HK$0.03.

During the past 12 months, Sino Biopharmaceutical's average Dividends Per Share Growth Rate was -58.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 13.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 17.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 19.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sino Biopharmaceutical was 58.70% per year. The lowest was -20.60% per year. And the median was 13.80% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Sino Biopharmaceutical Dividend Payout Ratio Historical Data

The historical data trend for Sino Biopharmaceutical's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Dividend Payout Ratio Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.25

0.36

0.05

0.84

0.75

Sino Biopharmaceutical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Dividend Payout Ratio	Get a 7-Day Free Trial															0.35	8.43	0.98	0.44	0.36

Competitive Comparison of Sino Biopharmaceutical's Dividend Payout Ratio

For the Biotechnology subindustry, Sino Biopharmaceutical's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Dividend Payout Ratio falls into.

Sino Biopharmaceutical Dividend Payout Ratio Calculation

Sino Biopharmaceutical's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0.081	/	0.108
	=	0.75

Sino Biopharmaceutical's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2024 )	/	EPS without NRI (Q: Jun. 2024 )
	=	0.03	/	0.084
	=	0.36

Sino Biopharmaceutical (HKSE:01177) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Sino Biopharmaceutical Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (HKSE:01177) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

SBHMY:USA SBMFF:USA SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2023, 37.8% of the firm's total revenue comes from five innovative drugs and five biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 33.6% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.

Executives

Tse Ping	2101 Beneficial owner
Tse Eric S Y	2101 Beneficial owner
Cheng Cheung Ling	2101 Beneficial owner
True Merit Global Limited	2101 Beneficial owner
Tse Theresa Y Y	2101 Beneficial owner
Thousand Eagles Limited	2101 Beneficial owner
France Investment (china 1) Group Limited	2101 Beneficial owner
Remarkable Industries Limited	2101 Beneficial owner
Validated Profits Limited	2101 Beneficial owner

Sino Biopharmaceutical Headlines

No Headlines